THIS THURSDAY!
Maybe Hydroxychloroquine will prove to be an appropriate treatment for COVID-19. Maybe it won’t.
But with all the attention it’s receiving in the media right now, there’s a good chance that pharmacy compounding professionals like you are being asked about it by patients or other healthcare professionals. They’re expecting you to be up-to-speed on all things HCQ – what it is, what it does, and how it might (or might not) help against coronavirus. They’ll expect you to know.
That’s why we’re offering this webinar on Hydroxychloroquine, which includes an update on the latest literature, just in time for those questions you’re fielding. Think of it as a refresher as well as a briefing on recent studies and trials that may have bearing in the current debate about the drug – so that you’ll feel more confident in understanding and answering questions about its current place in therapy.
Session Objectives:
– Describe the basic pharmacology, proposed mechanism of action, kinetics, and indications of hydroxychloroquine (HCQ)
– Discuss safety and considerations for use of HCQ
– Outline clinical trial and in vitro data on the use of HCQ for COVID-19
– Describe organization guidance, guidelines for treatment, and provide additional resources for ongoing clinical trials on the use of HCQ for COVID-1
Presenters:
– Allana Sucher, PharmD, BCPS, BCIDP, Professor of Pharmacy Practice, Regis University School of Pharmacy, Denver, CO
– T.J. Sayre, PharmD, MPH, BCPP, BCPS, Assistant Professor of Pharmacy Practice, Regis University School of Pharmacy, Denver, CO
– Dr. Miki Goldwire, PharmD, Professor and Director of Drug Information, Regis University School of Pharmacy, Denver, CO
APC is the voice for pharmacy compounding, representing compounding pharmacists, technicians, educators, students, researchers and suppliers. Compounding exists for patients and animals who are not served by traditional pharmaceutical manufacturers. Every day, APC members play a critical, often life-or-death role in patients’ lives, creating essential medications unavailable elsewhere for a range of issues, including autism, oncology, dermatology, ophthalmology, pediatrics, women’s health, and others. Learn more at www.a4pc.org.
